Learn More
Invitrogen™ ELISA-Kit für humanes hCG alpha
Beschreibung
The Human Chorionic Gonadotropin (hCG) ELISA quantitates Hu CG in human serum, plasma, or cell culture medium. The assay will exclusively recognize both natural and recombinant Hu CG. Principle of the method The Human CG solid-phase sandwich ELISA (enzyme-linked immunosorbent assay) is designed to measure the amount of the target bound between a matched antibody pair. A target-specific antibody has been pre-coated in the wells of the supplied microplate. Samples, standards, or controls are then added into these wells and bind to the immobilized (capture) antibody. The sandwich is formed by the addition of the second (detector) antibody, a substrate solution is added that reacts with the enzyme-antibody-target complex to produce measurable signal. The intensity of this signal is directly proportional to the concentration of target present in the original specimen. Rigorous validation Each manufactured lot of this ELISA kit is quality tested for criteria such as sensitivity, specificity, precision, and lot-to-lot consistency. See manual for more information on validation.
Spezifikation
Spezifikation
| Zugriffsnummer | P01215 |
| Assay-Bereich | 54,87 bis 40.000 pg/ml |
| Assay-Empfindlichkeit: | 50 pg/mL |
| Kalibrierbereich | 50 pg/mL to 40000 pg/mL |
| Assay | Festphasen-Sandwich-ELISA |
| Konjugat | Biotin |
| Produkttyp | ELISA-Kit |
| Proteinfamilie | Weitere Proteine |
| Probentyp | Plasma, Serum, Supernatant |
| Spezifität | Dieses ELISA-Kit weist keine Kreuzreaktivität mit den folgenden getesteten Zytokinen auf: humanes Angiogenin, BDNF, BLC, ENA-78, FGF-4, IL-1 alpha, IL-1 beta, IL-2, IL-3, IL-4, IL-5, IL-6, IL-7, IL-8, IL-9, IL-11, IL-12 p70, IL-12 p40, IL-13, IL-15, IL-309, IP-10, G-CSF, GM-CSF, IFN-gamma, Leptin (OB), MCP-1, MCP-2, MCP-3, MDC, MIP-1 alpha, MIP-1 beta, MIP-1 delta, PARC, PDGF, RANTES, SCF, TARC, TGF-beta, TIMP-1, TIMP-2, TNF-alpha, TNF-beta, TPO, VEGF. |
| Mehr anzeigen |
Bitte geben Sie uns Ihr Feedback zu den Produktinhalten, indem Sie das folgende Formular ausfüllen.